FRANKFURT, Germany (AP) — Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings.
Bayer said Monday it would launch a public offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion.
Conceptus makes Essure, an irreversible birth control method in which metal and polyester coils are inserted to block a woman's fallopian tubes. The procedure can be done in 10 minutes a doctor's office.
Conceptus CEO D. Keith Grossman was quoted in a Bayer statement as saying Essure "will benefit in new markets from Bayer's global presence."
The deal is subject to approval by antitrust authorities and could be completed by midyear.
Conceptus is based in Mountain View, California and employs about 300 people.
Why California Environmentalists Hate Water | Human Events
Peter Morici - 2015 Paris Climate Conference: Another Bad Deal for America
Guy Benson fact-checks Sally Kohn
5 Reasons I Will Not Vote For Trump If He Is The GOP Nominee | RedState
The Worst Gun Ever Made? - Bearing Arms - Calico, Video
Contained? New Report Says There’s ‘Unprecedented’ ISIS Mobilization In The U.S.
Reporter asks Ted Cruz four times: “How do you define amnesty?”